Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 24

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1
Chunk 24
---
16/02/2018 
    2018222777 
    01/02/2024 
    2018222777B9 
    2018222777 A 
    16/02/2038 
    granted
  
    CA 
    PCT 
    16/02/2018 
    305833 

    305833 A 
    16/02/2038 
    under examination
  
    CN 
    PCT 
    16/02/2018 
    201880012318.8 

    110291187 A 
    16/02/2038 
    under examination
  
    EP 
    PCT 
    16/02/2018 
    18 704 568.7 

    3 583 200 A 
    16/02/2038 
    under examination
  
    IN 
    PCT 
    16/02/2018 
    201917030262 

    201917030262 a 
    16/02/2038 
    under examination
  
    JP 
    PCT 
    16/02/2018 
    2019-544614 

    16/02/2038 
    under examination
  
    US 
    PCT 
    16/02/2018 
    16/486,425 
    20/04/2021 
    10980868B2 
    2020038496 A 
    16/02/2038 
    granted

VXM10 — PD-L1 (8)
WO 2018/167290, Novel PD-L1 targeting DNA vaccine for cancer immunotherapy

    Country Code 
    Type 
    Filing date 
    Filing no. 
    Grant Date 
    Grant no. 
    Publ. No. 
    Expiry 
    Status
  
    WO 
    PCT 
    16/02/2018 
    PCT/EP2018/056721 

    WO 2018/167290 
    — 

    CN 
    PCT 
    16/02/2018 
    201880018761.6 

    110430893 
    16/02/2038 
    under examination
  
    EP 
    PCT 
    16/02/201